Cargando…
β1-blocker in sepsis
BACKGROUND: The use of ultrashort-acting β1-blockers recently has attracted attention in septic patients with non-compensatory tachycardia. We summarized the metabolic and hemodynamic effects and the clinical evidence of ultrashort-acting β1-blockers. MAIN BODY: A recent meta-analysis showed that ul...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105957/ https://www.ncbi.nlm.nih.gov/pubmed/33964987 http://dx.doi.org/10.1186/s40560-021-00552-w |